CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-13 | Onyia Jude Chief Scientific Officer | Grant or award · Stock Option | +67,541 | 67,541 | ||
| 2023-02-13 | Onyia Jude Chief Scientific Officer | Grant or award · Restricted Stock Unit | +10,868 | 10,868 | ||
| 2023-02-13 | Lippoldt Darin Chief Legal Officer | Grant or award · Stock Option | +51,782 | 51,782 | ||
| 2023-02-13 | Lippoldt Darin Chief Legal Officer | Grant or award · Restricted Stock Unit | +8,332 | 8,332 | ||
| 2023-02-13 | GORMAN KEVIN CHARLES Chief Executive Officer | Grant or award · Stock Option | +133,656 | 133,656 | ||
| 2023-02-13 | GORMAN KEVIN CHARLES Chief Executive Officer | Grant or award · Restricted Stock Unit | +21,506 | 21,506 | ||
| 2023-02-13 | Gano Kyle Chief Business Development Off | Grant or award · Stock Option | +63,789 | 63,789 | ||
| 2023-02-13 | Gano Kyle Chief Business Development Off | Grant or award · Restricted Stock Unit | +10,264 | 10,264 | ||
| 2023-02-13 | Cooke Julie Chief Human Resources Officer | Grant or award · Stock Option | +37,523 | 37,523 | ||
| 2023-02-13 | Cooke Julie Chief Human Resources Officer | Grant or award · Restricted Stock Unit | +6,038 | 6,038 | ||
| 2023-02-13 | Boyer David W. Chief Corp. Affairs Officer | Grant or award · Stock Option | +45,027 | 45,027 | ||
| 2023-02-13 | Boyer David W. Chief Corp. Affairs Officer | Grant or award · Restricted Stock Unit | +7,245 | 7,245 | ||
| 2023-02-13 | BENEVICH ERIC Chief Commercial Officer | Grant or award · Stock Option | +51,782 | 51,782 | ||
| 2023-02-13 | BENEVICH ERIC Chief Commercial Officer | Grant or award · Restricted Stock Unit | +8,332 | 8,332 | ||
| 2023-02-13 | ABERNETHY MATT Chief Financial Officer | Grant or award · Stock Option | +63,789 | 63,789 | ||
| 2023-02-13 | ABERNETHY MATT Chief Financial Officer | Grant or award · Restricted Stock Unit | +10,264 | 10,264 | ||
| 2023-02-08 | Cooke Julie Chief Human Resources Officer | Sale | −700 | $103.95 | $73K | 28,052 |
| 2023-02-08 | Cooke Julie Chief Human Resources Officer | Sale | −628 | $103.69 | $65K | 27,424 |
| 2023-02-08 | ROBERTS EIRY Chief Medical Officer | Sale | −980 | $104.16 | $102K | 41,015 |
| 2023-02-08 | Lloyd-Smith Malcolm Chief Integration Officer | Sale | −701 | $103.83 | $73K | 42,337 |
Page 46 of 49 · 963 trades